JUDSON,
J.
(concurred
in
by
Abbott,
Martland,
Spence,
J.J.)
:—
In
these
proceedings,
which
are
by
way
of
petition
of
right,
the
two
Pfizer
Companies
seek
to
recover
sales
tax
paid
under
protest.
The
Customs
and
Excise
Division
began
to
exact
this
tax
following
a
declaration
of
the
Tariff
Board
in
March
of
1963,
which
held
that
“Metrecal”,
a
product
similar
to
the
one
with
which
we
are
here
concerned,
was
not
exempt
from
sales
tax.
The
judgment
of
the
Exchequer
Court
was
that
the
tax
was
payable.
In
my
opinion
this
Judgment
should
be
affirmed.
The
tax
is
imposed
by
Section
30
of
the
Excise
Tax
Act,
R.S.C.
1952,
c.
100,
which
reads
as
follows:
“30.
(1)
There
shall
be
imposed,
levied
and
collected
a
consumption
or
sales
tax
of
eight
per
cent
on
the
sale
price
of
all
goods
(a)
produced
or
manufactured
in
Canada.”
In
addition
to
this
sales
tax
there
is
a
3
per.
cent
old
age
security
tax
collected
with
it,
making
a
combined
tax
of
11
per
cent.
This
is
imposed
by
R.S.C.
1952,
c.
200,
Section
10.
To
be
exempt
the
product
must
come
within
Schedule
III
of
the
Excise
Tax
Act
and
the
appropriate
part
of
the
schedule
reads:
“Bakers’
cakes
and
pies
including
biscuits,
cookies
or
other
similar
articles
;”’
In
1963
the
following
words
were
added
after
‘‘similar
articles”;
“but
not
including
simulated
chocolate
bars
or
candy
bars;’’
The
addition
of
these
words
does
not
affect
the
decision
in
this
case.
The
product
in
question
is
sold
under
the
trade
mark
‘‘
Lim-
mits’’.
Pfizer
claims
that
it
is
a
food
product
in
biscuit
form
sold
and
advertised
for
sale
as
a
“limited
calorie
meal.
plan
for
weight
control’’.
It
was
made
and
baked
for
Pfizer
by
Christie,
Brown
&
Co.
Limited,
who
are
bakers.
The
baker
receives
its
manufacturing
instructions
from
Pfizer
but
not
all
the
information
as
to
the
contents
of
the
biscuit
is
communicated
to
the
baker.
Several
of
the
ingredients
are
referred
to
by
code
letters
alone.
In
the
reasons
for
judgment
of
Dumoulin,
J.,
there
is
a
full
reproduction
of
the
material
appearing
on
the
packet
of
biscuits,
including
directions
and
a
description
of
the
composition
of
the
product.
Briefly,
two
biscuits
are
recommended
to
replace
breakfast
or
lunch,
together
with
tea
or
coffee,
but
no
cream.
The
object
is
to
provide
a
nutritious,
satisfying,
calorie-limited
meal
in
biscuit
form
with
the
object
of
losing
weight.
The
contents
are
described
in
the
following
paragraph
:
“Contents
:
This
package
contains
6
Limmits.
Each
biscuit
weighing
1.14
oz.
contains
soya,
baking
and
whole
meal
flour,
sugar,
malt
extract,
glucose
syrup,
powdered
milk,
sodium
carboxymethyl
cellulose
(50
mg.)
and
the
following
essential
minerals
and
vitamins:
vitamin
A
(as
palmitate)
894
I.U.;
vitamin
B!
0.31
me.;
riboflavin
(vitamin
Bs)
0.52
mg.;
vitamin
C
10.74
mg.;
niacinamide
3.1
mg.;
calcium
(as
dibasic
calcium
phosphate)
115.4
mg.;
phosphorus
(as
dibasic
calcium
phosphate)
88.6
mg.;
iron
(as
reduced
iron)
2.5
mg.”
An
important
ingredient
mentioned
is
carboxymethyl
cellulose”.
This
is
described
as
‘‘a
bulking
agent
”
without
nutritional
value
which
swells
in
the
stomach
and
gives
a
feeling
of
fullness.
There
is
nothing
distinctive
about
the
shell
of
the
biscuits.
They
are
like
other
biscuits
in
this
respect.
Their
peculiarity
is
to
be
found
in
the
contents
above
described.
I
have
real
doubt
whether
they
can
be
described
as
biscuits
at
all.
I
think
this
word
means
the
ordinary,
everyday
product.
But
of
this
I
am
sure,
they
are
not
bakers’
biscuits”.
They
are
three
times
more
expensive
than
bakers’
biscuits.
They
are
advertised
and
sold
not
as
a
sweet
or
confection
but
as
an
elaborate,
calorie-
restricted
meal
for
the
purpose
of
reducing
weight.
Although
manufactured
by
a
baking
company,
they
are
produced
for
and
under
the
specific
direction
of
Pfizer
pursuant
to
a
detailed
formula
supplied
by
Pfizer
with
ingredients
compounded
and
provided
by
that
company.
Further,
as
already
mentioned,
a
number
of
the
ingredients
are
kept
secret
from
the
baking
company.
It
is
quite
true
that
many
foods
are
now
sold
with
vitamins
and
other
chemicals
added.
But
to
me
the
inert
appetite
depressant
sodium
carboxymethyl
cellulose”
and
its
function
to
create
the
impression
of
fullness
makes
it
impossible
to
hold
that
this
product
is
a
bakers’
biscuit”.
It
is
unnecessary
to
go
further
than
this.
It
is
neither
a
‘‘bakers’
biscuit”
nor
a
similar
article’’.
Dumoulin,
J.
put
his
judgment
on
three
grounds.
This
is
the
only
one
I
need
to
consider.
It
is
important
to
realize
that
under
the
Excise
Tax
Act
all
goods
produced
or
manufactured
in
Canada
are
subject
to
tax.
The
exempting
Section
32(1)
provides
that
32.
(1)
The
tax
imposed
by
section
30
does
not
apply
to
the
sale
or
importation
of
the
articles
mentioned
in
Schedule
III.”
It
is
not
enough
that
a
product.
may
be
described
as
a
foodstuff”.
To
be
exempt
it
must
be
a
specific
article
described
in
Schedule
IIT.
The
fact
that
one
of
the
sections
in
Schedule
III
is
headed
Foodstuffs”
does
not
govern
the
decision.
The
article
in
question
here
must
be
a
baker’s
biscuit’’
or
a
similar
article”.
This
means
the
ordinary
product
of
the
bakers’
art
and
it
is
certain
that
this
article
is
not
such
a
product.
I
would
dismiss
the
appeal
with
costs.
RITCHIE,
J.:—I
have
had
the
advantage
of
reading
the
reasons
for
judgment
of
my
brother
Judson
in
which
he
has
outlined
the
circumstances
giving
rise
to
this
appeal
and
has
cited
the
provisions
of
the
Excise
Tax
Act
pursuant
to
which
the
appellants
claim
exemption
for
their
products.
The
question
to
be
determined
on
this
appeal,
as
I
see
it,
is
whether
the
appellants’
products,
which
are
sold
under
the
trade
name
‘‘Limmits’’,
are
disentitled
to
the
exemption
from
sales
tax
which
is
extended
to
“bakers’
.
.
.
biscuits
.
.
.
or
other
similar
articles’’
as
“foodstuffs”
within
the
meaning
of
Schedule
IIII
to
the
Excise
Tax
Act,
by
reason
of
the
following
facts:
(a)
That
they
are
sold
or
represented
for
use
in
the
treatment,
mitigation
or
prevention
of
a
disorder
or
abnormal
physical
state
in
man,
namely
overweight;
(b)
that
they
are
produced
for,
and
under
the
specific
direction
of,
the
appellants
pursuant
to
a
detailed
chemical
formula
prescribed
by
them
and
for
which
they
supply
the
ingredients.
In
summarizing
his
reasons
for
deciding
that
“Limmits”
were
not
“foodstuffs”
within
the
meaning
of
the
Excise
Tax
Act,
Dumoulin,
J.
concluded
in
the
following
terms:
‘*
Above
all
else,
the
suprema
ratio
decidendi
is
that
Limmits’,
pursuant
to
the
clear
language
of
paragraph
(ce),
subsection
(1)
of
Section
2,
are
‘sold
or
represented’
in
such
a
way,
and
intended
to
secure
specified
results
that
unmistakably
stamp
them
with
the
statutory
qualifications
of
‘
als’.”’
The
relevant
provisions
of
Section
2(1)
of
the
Act
read
as
follows
:
“
(cc)
‘pharmaceuticals’
means
any
material,
substance,
mixture,
compound
or
preparation,
of
whatever
composition
or
in
whatever
form,
sold
or
represented
for
use
in
the
diagnosis,
treatment,
mitigation
or
prevention
of
a
disease,
disorder,
abnormal
physical
state,
or
the
symptoms
thereof,
in
man
or
animal,
or
for
restoring,
correcting
or
modifying
organic
functions
in
man
or
animal;
.
..”?
In
the
course
of
his
reasons
for
judgment,
Dumoulin,
J;
placed
the
following
interpretation
on
the
words
‘‘sold
or
represented”
as
they
occur
in
this
subsection
:
Tn
my
humble
opinion
those
three
governing:
words
have
paramount
sway
over
the
Act
and
are
mandatory
unless
superseded
by
an
exception,
expressed
or
logically
inferred.
It
was
convincingly
shown,
I
believe,
that
the
particular
products,
in
biscuit
form,
called
Limmits,
were
‘sold
or
repre-
sented’
to
the
public
at
large
precisely
in
the
manner
and
for
the
purposes
foreseen
by
Section
2(1)
(cc).
How,
then,
could
they
escape
the
consumption
taxes
of
eight
per
cent
and
three
per
cent
imposed,
respectively,
by
the
Excise
Tax
Act
and
Old
Age
Security
Act?”
Later
in
his
judgment,
the
learned
judge
explained
what
he
found
to
be
the
mandatory
condition
of
the
tax
exemption
in
Schedule
III
in
the
following
terms
:
'The
determining,
decisive,
factor
does
not
consist
in
the
quantity
of
vitamins
contained
in,
or
calories
excluded
from,
an
edible
substance;
it
is
set
and
prescribed
by
the
interpretative
authority
of
Section
2(1)
(ec)
decreeing
that:
must
be
considered
pharmaceuticalsunmentioned
in
Schedule
ITT,
‘any
material,
substance,
mixture,
compound
or
preparation,
of
whatever
composition
or
in
whatever
form,
sold
or
represented
for
use
in
the
.
.
.
treatment,
mitigation
or
prevention
of
a
.
.
.
disorder
(or)
abnormal
state
.
.
.
in
man’.”
With
the
greatest
respect
for
those
who
may
hold
a
different
view,
I
do
not
regard
the
subsection
to
which
Dumoulin,
J.
refers
as
effective
to
do
more
than
to
define
the
meaning
which
Parliament
intended
to
be
attached
to
the
word
“pharmaceutical”
a
it
is
used
from
time
to
time
in
the
Excise
Tax
Act,
and
I
do
not
think
that
it
has
the
effect
of
creating
a
distinct
class
of
substance
in
contra-distinction
to
and
exclusion
of
the
“foodstuffs”
described
in
Schedule
III.
If
the
definition
of
“pharmaceutical”
had
this
effect
it
would
mean,
in
my
view,
that
‘‘foodstuffs’’
which
would
otherwise
come
within
the
exemption
provided
by
that
schedule
would,
if
they
were
sold
or
represented
for
‘‘use
in
.
.
.
modifying
organic
functions
in
man
or
animal”,
cease
to
be
“foodstuffs”
for
the
purpose
of
the
statute.
It
occurs
to
me
that
this
would
mean,
for
example,
that
upon
a
manufacturer
representing
that
a
particular
‘‘foodstuff’’
was
beneficial
for
use
by
those
suffering
from
indigestion,
the
product
so
represented
would
cease
to
be
a
‘‘foodstuff’’
within
the
meaning
of
the
schedule
and
would
become
subject
to
excise
tax
as
a
“pharmaceutical”.
In
my
opinion
the
character
of
the
product
for
the
purpose
of
entitling
it
to
an
exemption
as
a
‘‘foodstuff’’
under
Schedule
III
is
in
no
sense
altered
by
the
way
in
which
it
is
sold
or
represented
by
the
manufacturer
or
by
the
price
charged
for
it.
The
appellants’
products
are
baked
by
a
bakery
company
and
each
consists
of
two
small
biscuits
between
which
is
inserted
a
flavoured
filling
prepared
according
to
a
formula
supplied
by
the
appellants
which
contains
chemical
constituents,
including
the
appetite
depressant,
sodium
carboxymethylcellulose.
Although
it
is
not
expressly
admitted
that
the
so-called
shells
on
each
side
of
the
filling
are
the
same
as
the
shell
on
any
ordinary
biscuit,
the
description
given
on
behalf
of
the
appellants
by
S.
A.
B.
Dean
remains
uncontradicted.
That
witness
said:
‘
The
shells
of
the
biscuit
are
baked
in
equipment
used
for
the
manufacture
of
all
other
type
of
biscuits;
and
the
ingredients
that
enter
into
the
process
are
of
necessity
the
same
type
of
ingredients
that
go
into
ordinary
everyday
biscuits
.
.
.’’
It
is,
however,
contended
on
behalf
of
the
respondent
that
the
chemical
constituents
of
the
filling
distinguish
the
product
from
the
usual
bakers’
biscuits
and
exclude
it
from
the
class
of
“Foodstuffs”
prescribed
by
Schedule
III
to
the
Excise
Tax
Act.
The
class
of
“Foodstuffs”
under
which
the
exemption
is
here
sought
is
described
in
the
schedule
as
‘‘bakers’
cakes
and
pies,
including
biscuits,
cookies
or
other
similar
articles’?
(the
italics
are
my
own).
While
I
agree
that
the
special
properties
contained
in
the
filling
which
is
inserted
between
the
two
small
biscuits
in
the
preparation
of
‘‘Limmits’’
differentiate
them
from
ordinary
‘‘bakers’
biscuits’’,
I
am
nevertheless
of
the
opinion,
with
the
greatest
respect
for
those
who
hold
a
different
view,
that
the
effect
of
inserting
the
prepared
filling
is
to
make
the
finished
products
a
somewhat
unusual
type
of
‘‘bakers’
biscuits”
with
special
dietary
qualities
which
are
said
to
aid
in
the
treatment
of
obesity,
but
that
they
remain
‘‘bakers’
biscuits”
and
as
such
are
exempt
under
the
schedule.
Even
if
I
were
not
satisfied
that
‘‘Limmits’’
were
‘‘bakers’
biscuits”?
within
the
meaning
of
the
statute,
I
would
not
be
prepared
to
say
that,
baked
as
they
are
in
a
baker’s
oven
with
two
sides
which
are
indistinguishable
from
ordinary
‘‘bakers’
biscuits”?
they
are
not,
at
least,
‘‘similar’’
to
such
biscuits
and
therefore
“similar
articles’?
within
the
meaning
of
the
schedule
and
entitled
to
the
exemption
for
which
provision
is
made
under
Section
32(1)
of
the
Excise
Tax
Act,
which
also
applies
to
the
tax
imposed
by
the
Old
Age
Security
Act.
I
would
accordingly
allow
this
appeal
and
order
that
the
Pfizer
Corporation
is
entitled
to
recover
from
the
respondent
the
sum
of
$15,818.44
and
that
the
Pfizer
Company
Limited
is
entitled
to
recover
the
sum
of
$43,417.18
being
the
amounts
paid
under
the
Excise
Tax
Act
and
the
Old
Age
Security
Act
by
way
of
sales
tax
and
old
age
security
tax
in
respect
of
these
products
between
February
25,
1963
and
January
31,
1964
together
with
interest
on
both
amounts
at
the
rate
of
five
per
cent
from
the
date
of
service
of
the
petition
of
right
herein.
I
would
award
the
appellants
their
costs
in
this
Court
and
in
the
Exchequer
Court.